- Home
- PDO vs INVA Comparison
PDO vs INVA Comparison
Compare PDO & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$20.66
Company Overview
Basic Information| Metric | PDO | INVA |
|---|---|---|
| Founded | 2020 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | PDO | INVA |
|---|---|---|
| Price | $12.36 | $20.66 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $32.80 |
| AVG Volume (30 Days) | ★ 929.5K | 549.5K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 11.80% | N/A |
| EPS Growth | N/A | ★ 816.67 |
| EPS | N/A | ★ 1.25 |
| Revenue | N/A | ★ $217,217,000.00 |
| Revenue This Year | N/A | $8.95 |
| Revenue Next Year | N/A | $12.65 |
| P/E Ratio | ★ N/A | $16.90 |
| Revenue Growth | N/A | ★ 62.63 |
| 52 Week Low | $12.36 | $16.52 |
| 52 Week High | $14.25 | $25.15 |
Technical Indicators
Market Signals| Indicator | PDO | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 43.34 | 42.40 |
| Support Level | $12.40 | $20.44 |
| Resistance Level | $13.20 | $21.91 |
| Average True Range (ATR) | 0.16 | 0.38 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 32.63 | 11.11 |
Price Performance
Historical Comparison PDO
INVA
About PDO PIMCO Dynamic Income Opportunities Fund of Beneficial Interest
PIMCO Dynamic Income Opportunities Fund is a closed-end management investment company. The fund's primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.